Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grantham

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Journal of the American Society of Nephrology : JASN|June 22, 2007
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney diseaseSandro Rossetti, Mark B Consugar, Arlene B Chapman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipientsMe-Linh Luong, Cornelius J Clancy, Aniket Vadnerkar, et al.
Kidney International|December 21, 2016
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney diseaseVicente E Torres, Kaleab Z Abebe, Robert W Schrier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 21, 2012
Kidney volume and functional outcomes in autosomal dominant polycystic kidney diseaseArlene B Chapman, James E Bost, Vicente E Torres, et al.
Kidney International Reports|April 29, 2021
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney DiseaseMireille El Ters, Pengcheng Lu, Jonathan D Mahnken, et al.
Kidney International|November 25, 2003
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney diseaseBernard F King, Vicente E Torres, Marijn E Brummer, et al.
The New England Journal of Medicine|May 19, 2006
Volume progression in polycystic kidney diseaseJared J Grantham, Vicente E Torres, Arlene B Chapman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney diseaseVicente E Torres, Bernard F King, Arlene B Chapman, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trialsMaría V Irazabal, Laureano J Rangel, Eric J Bergstralh, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohortKyongtae T Bae, Fang Zhu, Arlene B Chapman, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Journal of the American Society of Nephrology : JASN|June 22, 2007
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney diseaseSandro Rossetti, Mark B Consugar, Arlene B Chapman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipientsMe-Linh Luong, Cornelius J Clancy, Aniket Vadnerkar, et al.
Kidney International|December 21, 2016
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney diseaseVicente E Torres, Kaleab Z Abebe, Robert W Schrier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 21, 2012
Kidney volume and functional outcomes in autosomal dominant polycystic kidney diseaseArlene B Chapman, James E Bost, Vicente E Torres, et al.
Kidney International Reports|April 29, 2021
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney DiseaseMireille El Ters, Pengcheng Lu, Jonathan D Mahnken, et al.
Kidney International|November 25, 2003
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney diseaseBernard F King, Vicente E Torres, Marijn E Brummer, et al.
The New England Journal of Medicine|May 19, 2006
Volume progression in polycystic kidney diseaseJared J Grantham, Vicente E Torres, Arlene B Chapman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney diseaseVicente E Torres, Bernard F King, Arlene B Chapman, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trialsMaría V Irazabal, Laureano J Rangel, Eric J Bergstralh, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohortKyongtae T Bae, Fang Zhu, Arlene B Chapman, et al.
Pageof 23